These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3291460)

  • 1. Conformational restriction of peptidyl immunogens with covalent replacements for the hydrogen bond.
    Satterthwait AC; Arrhenius T; Hagopian RA; Zavala F; Nussenzweig V; Lerner RA
    Vaccine; 1988 Apr; 6(2):99-103. PubMed ID: 3291460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The conformational restriction of synthetic peptides, including a malaria peptide, for use as immunogens.
    Satterthwait AC; Arrhenius T; Hagopian RA; Zavala F; Nussenzweig V; Lerner RA
    Philos Trans R Soc Lond B Biol Sci; 1989 Jun; 323(1217):565-72. PubMed ID: 2569211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The conformational restriction of synthetic vaccines for malaria.
    Satterthwait AC; Chiang LC; Arrhenius T; Cabezas E; Zavala F; Dyson HJ; Wright PE; Lerner RA
    Bull World Health Organ; 1990; 68 Suppl(Suppl):17-25. PubMed ID: 2094582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antibody response in mice to carrier-free synthetic polymers of Plasmodium falciparum circumsporozoite repetitive epitope is I-Ab-restricted: possible implications for malaria vaccines.
    Del Giudice G; Cooper JA; Merino J; Verdini AS; Pessi A; Togna AR; Engers HD; Corradin G; Lambert PH
    J Immunol; 1986 Nov; 137(9):2952-5. PubMed ID: 3531341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteosome-hydrophobic 'foot' malaria peptide vaccines for Plasmodium falciparum and P. vivax.
    Lowell GH; Ballou WR; Smith LF; Zollinger WD; Hockmeyer WT
    Trans R Soc Trop Med Hyg; 1989; 83 Suppl():101-2. PubMed ID: 2696152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of immunogens for synthetic malaria vaccines.
    Lise D; Dubeaux C; Tello D; Mazier D; Jolivet M; Schlesinger DH; Audibert F; Chedid L
    Biochem Biophys Res Commun; 1988 May; 153(1):31-8. PubMed ID: 3288205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites.
    Herrington DA; Clyde DF; Losonsky G; Cortesia M; Murphy JR; Davis J; Baqar S; Felix AM; Heimer EP; Gillessen D
    Nature; 1987 Jul 16-22; 328(6127):257-9. PubMed ID: 2439920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A structure-based approach to a synthetic vaccine for HIV-1.
    Cabezas E; Wang M; Parren PW; Stanfield RL; Satterthwait AC
    Biochemistry; 2000 Nov; 39(47):14377-91. PubMed ID: 11087390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformational preferences of synthetic peptides derived from the immunodominant site of the circumsporozoite protein of Plasmodium falciparum by 1H NMR.
    Dyson HJ; Satterthwait AC; Lerner RA; Wright PE
    Biochemistry; 1990 Aug; 29(34):7828-37. PubMed ID: 2261440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale for development of a synthetic vaccine against Plasmodium falciparum malaria.
    Zavala F; Tam JP; Hollingdale MR; Cochrane AH; Quakyi I; Nussenzweig RS; Nussenzweig V
    Science; 1985 Jun; 228(4706):1436-40. PubMed ID: 2409595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment in humans of a synthetic peptide-based vaccine against the sporozoite stage of the human malaria parasite, Plasmodium falciparum.
    Etlinger HM; Felix AM; Gillessen D; Heimer EP; Just M; Pink JR; Sinigaglia F; Stürchler D; Takacs B; Trzeciak A
    J Immunol; 1988 Jan; 140(2):626-33. PubMed ID: 3275719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of protective immunity against experimental infection with malaria using synthetic peptides.
    Patarroyo ME; Romero P; Torres ML; Clavijo P; Moreno A; Martínez A; Rodríguez R; Guzman F; Cabezas E
    Nature; 1987 Aug 13-19; 328(6131):629-32. PubMed ID: 3302727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential non-responsiveness in humans of candidate Plasmodium falciparum vaccine antigens.
    Quakyi IA; Otoo LN; Pombo D; Sugars LY; Menon A; De Groot AS; Johnson A; Alling D; Miller LH; Good MF
    Am J Trop Med Hyg; 1989 Aug; 41(2):125-34. PubMed ID: 2672834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A totally synthetic polyoxime malaria vaccine containing Plasmodium falciparum B cell and universal T cell epitopes elicits immune responses in volunteers of diverse HLA types.
    Nardin EH; Calvo-Calle JM; Oliveira GA; Nussenzweig RS; Schneider M; Tiercy JM; Loutan L; Hochstrasser D; Rose K
    J Immunol; 2001 Jan; 166(1):481-9. PubMed ID: 11123327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune protection-inducing protein structures (IMPIPS) against malaria: the weapons needed for beating Odysseus.
    Patarroyo ME; Patarroyo MA; Pabón L; Curtidor H; Poloche LA
    Vaccine; 2015 Dec; 33(52):7525-37. PubMed ID: 26469723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theoretically determined three-dimensional structure for the repeating tetrapeptide unit of the circumsporozoite coat protein of the malaria parasite Plasmodium falciparum.
    Brooks BR; Pastor RW; Carson FW
    Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4470-4. PubMed ID: 3299369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new helicoid-type sequential oligopeptide carrier (SOC(n)) for developing potent antigens and immunogens.
    Sakarellos-Daitsiotis M; Tsikaris V; Sakarellos C; Vlachoyiannopoulos PG; Tzioufas AG; Moutsopoulos HM
    Vaccine; 1999 Sep; 18(3-4):302-10. PubMed ID: 10506655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards the design of heterovalent anti-malaria vaccines: a hybrid immunogen capable of eliciting immune responses to epitopes of circumsporozoite antigens from two different species of the malaria parasite, Plasmodium.
    Kironde FA; Rao KV; Shah S; Kumar A; Sahoo N
    Immunology; 1991 Oct; 74(2):323-8. PubMed ID: 1721043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging rules for subunit-based, multiantigenic, multistage chemically synthesized vaccines.
    Patarroyo ME; Patarroyo MA
    Acc Chem Res; 2008 Mar; 41(3):377-86. PubMed ID: 18266328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2.
    Wizel B; Houghten RA; Parker KC; Coligan JE; Church P; Gordon DM; Ballou WR; Hoffman SL
    J Exp Med; 1995 Nov; 182(5):1435-45. PubMed ID: 7595214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.